Capital Advisors »

Crispr Therapeutics shares owned by Capital Advisors

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Capital Advisors from 13F filings

Historical chart of Capital Advisors investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Capital Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $16M 255k 62.60
2023-09-30 $11M 232k 45.39
2023-06-30 $12M 216k 56.14
2023-03-31 $7.5M 166k 45.23
2022-12-31 $5.3M 130k 40.65
2022-09-30 $6.9M 128k 54.07
2022-06-30 $7.7M 126k 60.77
2022-03-31 $6.6M 105k 62.77
2021-12-31 $7.8M 103k 75.78
2021-09-30 $7.9M 71k 111.93
2021-06-30 $11M 70k 161.89
2021-03-31 $8.3M 68k 121.85
2020-12-31 $13M 88k 153.11
2020-09-30 $12M 137k 83.64
2020-06-30 $13M 137k 92.94
2020-03-31 $5.7M 134k 42.41
2019-12-31 $7.7M 127k 60.91
2019-09-30 $5.5M 116k 47.10
2019-06-30 $5.5M 116k 47.10
2019-03-31 $1.9M 53k 35.73
2018-12-31 $3.4M 118k 28.57
2018-09-30 $4.8M 107k 44.35
2018-06-30 $6.3M 106k 58.76
2018-03-31 $6.8M 149k 45.71
2017-12-31 $3.5M 150k 23.48